期刊文献+

甲状腺机能减退征患者红细胞膜Ca^(2+).Mg^(2+)-ATPase活性测定

The Measuremant of Erythrocyte Membrane Ca^(+2).Mg^(2+)-ATPase in Patients with Hypothyroidism
下载PDF
导出
摘要 目的了解红细胞膜钙-镁三磷酸腺苷酶(Ca2+.Mg2+-ATPase)活性在甲状腺功能减退征患者中的变化及该酶活性是否随甲状腺功能的恢复而逆转至正常,以确定该酶活性可否作为甲状腺激素在细胞水平作用的一个指标。方法低温、低渗溶解红细胞,差速离心法制备红细胞膜悬液。酶活性以含酶的红细胞膜悬液水解底物ATP释放出无机磷的量表示,无钙条件下无机磷的产生量为Mg2+-ATPase活性,有钙条件下无机磷的产生量为总ATPase活性,二者之差为Ca2+.Mg2+-ATPase活性。结果甲状腺功能减退患者红细胞Ca2+.Mg2+-ATPase活性明显低于正常组。但3月后,随着甲状腺功能恢复正常,酶活性也随之恢复正常。结论红细胞膜Ca2+.Mg2+-ATPase活性可作为甲状腺激素在细胞水平作用的一个指标,用于甲状腺功能异常的辅助诊断。 Objective To determine if the erythrocyte membrane Ca^2+. Mg^2+ - ATPase activity can be an index which response the function of thyroid hormone in the cellular level, the enzyme activity were measured in patients with hypothyroidism and re - examined in euthyroid state after 3 months L - T4 replacement. Methods The erythrocyte membrane was prepared by hypotonic - lyses and different centrifugation under 4℃. The enzyme activity was expressed by the amount of released phosphorus (Pi) from ATP under the catalyzed of membrane solution. The released Pi with calcium was act as Total - ATPsae and the Pi without calcium is act as Mg^2+ - ATPase, the Ca^2+. Mg^2+ - ATPase was obtained by the difference of the two. Results The activity was significantly decreased in the hypothyroidism and returned to normal after euthyroid was achieved by 3 months of Ca^2+. Mg^2+ replacement treatment. Conclusion This study provides clinical confirmation of suggesting that the set - point of Ca^2 +. Mg^2 + - ATPase activity is, in part, a function of endogenous thyroid hormone levels. This enzyme may be an index which response the function of thyroid hormone in the cell level and may be helpful for the diagnosis of thyroid disease.
出处 《医药论坛杂志》 2006年第12期16-17,共2页 Journal of Medical Forum
关键词 甲状腺功能减退征 红细胞膜钙-镁三磷酸腺苷酶 活性 Hypothyroidism Erythrocyte membrane Ca2^+. Mg^2+ - ATPase Activity
  • 相关文献

参考文献4

  • 1栗夏莲,翟绍忠,孙良阁.甲状腺激素对心肌肌质网钙、镁-三磷酸腺苷酶活性的影响及心得安的干预作用[J].内科急危重症杂志,2005,11(4):164-165. 被引量:1
  • 2Zabrocka L,Klimek J.Molecular mechanism of thyroid hormone action.Postepy Biochem,2004,50 (1):57 -68
  • 3Hogstrand C,Verbost PM,Wendelaar Bonga SE.Inhibition of human erythrocyte Ca^2+ -ATPase gy Zh^2+.Toxicology,1999,133 (2):139-145
  • 4Odcikin E,Ozdemir H,Ciftci M,Capoglu I.Investigation of red blood cell carbonic anhydrase,glucose 6-phosphate dehydrogenase,hexokinase enzyme activities,and zinc concentration in patients with hyperthyrod diseases.Endocr Res,2002,28(1):61-68

二级参考文献14

  • 1栗夏莲,欧阳安,周慕英,赵根尚.心得安对模拟甲状腺功能亢进兔心功能的作用[J].天津医药,1989,17(6):342-344. 被引量:1
  • 2Narayanan N. Differential alterations in ATP-supported calcium transport activities of sarcoplasmic reticulum and sarcolemma of aging myocardium. Biochim Biophys Acta,1981,678:442.
  • 3徐友涵 宋陆华.一种简便、敏感的三磷酸腺苷酶活性测定方法[J].生物化学及生物物理学进展,1986,4:64-64.
  • 4Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurements with the Folin phenol reagent. J Biol Chem, 1951,193:265.
  • 5Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med, 1990,88 : 626.
  • 6Davis PJ, Davis FB. Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg , 1993,56 : S16.
  • 7Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med, 1990,88: 642.
  • 8Hoit BD, Khoury SF, Shao Y, et al. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons.Circulation, 1997,96: 592.
  • 9Ojamaa K, Kenessey A, Klein I. Thyroid Hormone Regulation of Phospholamban Phosphorylation in the Rat Heart. Endocrinology, 2000,141: 2139.
  • 10Biondi B, Fazio S, Carella C, et al. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving longterm suppressive therapy with levothyroxine. J Clin Endocrinol Metab, 1994,78:1028.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部